Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
12/01/2009
Trade Name:
Patanase
Generic or Proper Name (*):
olopatadine
Indications Studied:
Seasonal allergic rhinitis
Therapeutic Category:
Antihistamine
Ages Studied:
2-11 years
Study #:
2
Study Type:
Safety/Pharmacokinetic in 2 to <6 years
Study Design:
Single-Blind/Placebo/Parallel Group\Population Pharmacokinetic
No Patients:
132
No Centers:
9
No Countries:
1
BPCA(B), PREA(P):
B, P
Asian:
2
Black:
56
Other:
7
White:
133
Native Hawaiian or Pacific Islander:
0
American Indian/Alaska Native:
0
Hispanic/Latino:
0
Non-Hispanic/Non Latino:
0
-
-